Ischemic preconditioning, myocardial stunning and anesthesia

Current Opinion in Anaesthesiology

Volumn 13, Issue 1, 2000, Pages 35-40

  Toller, Wolfgang G ^a,b   Kersten, Judy R ^a   Pagel, Paul S ^a   Warltier, David C ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; DESFLURANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; POTASSIUM; POTASSIUM CHANNEL; SEVOFLURANE;

CORONARY ARTERY BLOOD FLOW; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; STUNNED HEART MUSCLE;

EID: 0034059302     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-200002000-00006     Document Type: Review

References (71)

1. 1 Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74:1124-1136.
2. 2 Tomai F, Crea F, Chiariello L, Gioffre PA. Ischemic preconditioning in humans. Models, mediators, and clinical relevance. Circulation 1999; 100:559-563. This review summarizes the present position of IPC in humans.
3. 3 Yellon DM, Baxter GF, Garcia-Dorado D, Heusch G, Sumeray MS. Ischaemic preconditioning: present position and future directions. Cardiovasc Res 1998; 37:21-33. This review is highly informative, covers the present role of IPC and presents interesting future perspectives.
4. 4 Jenkins DP, Pugsley WB, Alkhulaifi AM, Kemp M, Hooper J, Yellon DM. Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart 1997; 77:314-318.
5. 5 Przyklenk K, Kloner RA. Ischemic preconditioning: exploring the paradox. Prog Cardiovasc Dis 1998; 40:517-547. This is a very comprehensive review of the current information about IPC.
6. 6 Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982; 66:1146-1149.
7. 7 Bolli R. Mechanism of myocardial 'stunning'. Circulation 1990; 82:723-738.
8. 8 Kloner RA, Bolli R, Marban E, Reinlib L, Braunwald E. Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop. Circulation 1998; 97:1848-1867. This is a concise review of the pathogenesis of myocardial stunning and hibernation.
9. 9 Bolli R, Zhu WX, Thornby JI, O'Neill PG, Roberts R. Time course and determinants of recovery of function after reversible ischemia in conscious dogs. Am J Physiol 1988; 254:H102-H114.
10. 10 Charlat ML, O'Neill PG, Hartley CJ, Roberts R, Bolli R. Prolonged abnormalities of left ventricular diastolic wall thinning in the 'stunned' myocardium in conscious dogs: time course and relation to systolic function. J Am Coll Cardiol 1989; 13:185-194.
11. ATP channels in mediating myocardial protection.
12. ATP channels in ischemic and anesthetic-induced preconditioning.
13. 13 Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992; 70:223-233.
14. + channel blocker. Circulation 1994; 90:700-705.
15. 15 Yao Z, Gross GJ. Activation of ATP-sensitive potassium channels lowers threshold for ischemic preconditioning in dogs. Am J Physiol 1994; 267:H1888-H1894.
16. + channels protect the myocardium against ischemia/reperfusion damage. Circ Res 1991; 69:571-581.
17. ATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation 1994; 89:1769-1775.
18. ATP opener cromakalim is not correlated with ischemic myocardial action potential duration. J Cardiovasc Pharmacol 1995; 26:145-152.
19. + blocker dofetilide. Am J Physiol 1996; 271:H1207-H1214.
20. ATP channel-opener to provide cardioprotective effects.
21. 21 Multicenter Post Infarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983; 309:331-336.
22. 22 Hawaleshka A, Jacobsohn E. Ischaemic preconditioning: mechanisms and potential clinical applications. Can J Anaesth 1998; 45:670-682. This review article focuses on potential clinical applications of IPC.
23. 23 Galinanes M, Wilson AN, Hearse DJ. Impaired cardioplegic delivery and the loss of cardioprotection: a role for preconditioning. J Mol Cell Cardiol 1997; 29:849-854.
24. 24 Jacobsohn E, Young CJ, Aronson S, Ferdinand FD, Albertucci M. The role of ischemic preconditioning during minimally invasive coronary artery bypass surgery. J Cardiothorac Vasc Anesth 1997; 11:787-792.
25. 25 Brady PA, Terzic A. The sulfonylurea controversy: more questions from the heart. J Am Coll Cardiol 1998; 31:950-956. The authors discuss the present role of antidiabetic drugs in IPC.
26. 26 Meinert CL, Knatterud GL, Prout TE, Klimt CR. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes 1970; 19(suppl):789-830.
27. 27 Cleveland JC Jr, Meldrum DR, Cain BS, Banerjee A, Harken AH. Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited. Circulation 1997; 96:29-32.
28. ATP channels: reduction of myocardial infarct size with an acute memory phase. Anesthesiology 1997; 87:361-370.
29. 29 Ismaeil MS, Tkachenko I, Gamperl AK, Hickey RF, Cason BA. Mechanisms of isoflurane-induced myocardial preconditioning in rabbits. Anesthesiology 1999; 90:812-821.
30. 30 Toller WG, Kersten JR, Pagel PS, Hettrick DA, Warltier DC. Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs. Anesthesiology 1999; 91:1437-1446.
31. ATP) channels: mechanism of desflurane-induced cardioprotection. Anesthesiology 2000; 92: (in press).
32. 32 Cason BA, Gamperl AK, Slocum RE, Hickey RF. Anesthetic-induced preconditioning: previous administration of isoflurane decreases myocardial infarct size in rabbits. Anesthesiology 1997; 87:1182-1190.
33. 33 Cope DK, Impastato WK, Cohen MV, Downey JM. Volatile anesthetics protect the ischemic rabbit myocardium from infarction. Anesthesiology 1997; 86:699-709.
34. 34 Belhomme D, Peynet J, Louzy M, Launay JM, Kitakaze M, Menasché P. Evidence for preconditioning by isoflurane in coronary bypass surgery. Circulation 1999; 100[suppl II]:II-340-II-344.
35. 35 Kersten JR, Orth KG, Pagel PS, Mei DA, Gross GJ, Warltier DC. Role of adenosine in isoflurane-induced cardioprotection. Anesthesiology 1997; 86:1128-1139.
36. 36 Toller WG, Montgomery MW, Pagel PS, Hettrick DA, Warltier DC, Kersten JR. Isoflurane-enhanced recovery of canine stunned myocardium: a role for protein kinase C? Anesthesiology 1999; 91:713-722.
37. 37 Downey JM, Cohen MV. Signal transduction in ischemic preconditioning. Z Kardiol 1995; 84:77-86.
38. 38 Preuss KC, Gross GJ, Brooks HL, Warltier DC. Time course of recovery of 'stunned' myocardium following variable periods of ischemia in conscious and anesthetized dogs. Am Heart J 1987; 114:696-703.
39. 39 Bolli R, Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev 1999; 79:609-634. This review article describes in detail two major theories of myocardial stunning.
40. 40 Bolli R. Causative role of oxyradicals in myocardial stunning: a proven hypothesis. Basic Res Cardiol 1998; 93:156-162.
41. 41 Sun JZ, Tang XL, Park SW, Oiu Y, Turrens JF, Bolli R. Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest 1996; 97:562-576.
42. 42 Bolli R. Role of neutrophils in myocardial stunning after brief ischaemia: the end of a six year old controversy (1987-1993). Cardiovasc Res 1993; 27:728-730.
43. 43 Xia Y, Zweier JL. Substrate control of free radical generation from xanthine oxidase in the postischemic heart. J Biol Chem 1995; 270:18797-18803.
44. 44 Carrozza JP Jr, Bentivegna LA, Williams CP, Kuntz RE, Grossman W, Morgan JP. Decreased myofilament responsiveness in myocardial stunning follows transient calcium overload during ischemia and reperfusion. Circ Res 1992; 71:1334-1340.
45. 45 Gao WD, Atar D, Liu Y, Perez NG, Murphy AM, Marban E. Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circ Res 1997; 80:393-399.
46. 2+ sensitivity of tension during stunning in porcine myocardium. J Mol Cell Cardiol 1996; 28:689-697.
47. 47 Bolli R. Myocardial 'stunning' in man. Circulation 1992; 86:1671-1691.
48. 48 Homans DC, Sublett E, Lindstrom P, Nesbitt T, Bache RJ. Subendocardial and subepicardial wall thickening during ischemia in exercising dogs. Circulation 1988; 78:1267-1276.
49. 49 Hittinger L, Shannon RP, Kohin S, Manders WT, Kelly P, Vatner SF. Exercise-induced Subendocardial dysfunction in dogs with left ventricular hypertrophy. Circ Res 1990; 66:329-343.
50. 50 Gross GJ, Farber NE, Hardman HF, Warltier DC. Beneficial actions of Superoxide dismutase and catalase in stunned myocardium of dogs. Am J Physiol 1986; 250:H372-H377.
51. 51 Park SW, Tang XL, Qiu Y, Sun JZ, Bolli R. Nisoldipine attenuates myocardial stunning induced by multiple coronary occlusions in conscious pigs and this effect is independent of changes in hemodynamics or coronary blood flow. J Mol Cell Cardiol 1996; 28:655-666.
52. 52 Heusch G. Myocardial stunning: a role for calcium antagonists during ischaemia? Cardiovasc Res 1992; 26:14-19.
53. 53 Przyklenk K, Kloner RA. Effect of verapamil on postischemic 'stunned' myocardium: importance of the timing of treatment. J Am Coll Cardiol 1988; 11:614-623.
54. 54 Taylor AL, Golino P, Eckels R, Pastor P, Buja LM, Willerson JT. Differential enhancement of postischemic segmental systolic thickening by diltiazem. J Am Coll Cardiol 1990; 15:737-747.
55. 55 Sekili S, Jeroudi MO, Tang XL, Zughaib M, Sun JZ, Bolli R. Effect of adenosine on myocardial 'stunning' in the dog. Circ Res 1995; 76:82-94.
56. 56 Kloner RA, Kirshenbaum J, Lange R, Antman EM, Braunwald E. Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia. Am J Cardiol 1985; 56:40F-48F.
57. 57 Gross GJ, Daemmgen JW. Beneficial effects of two specific bradycardic agents AQ-A39 (falipamil) and AQ-AH 208 on reversible myocardial reperfusion damage in anesthetized dogs. J Pharmacol Exp Ther 1986; 238:422-428.
58. 2+ sensitization predominantly enhances function and mechanical efficiency of stunned myocardium. Circulation 1994; 90:959-969.
59. 59 Ehring T, Baumgart D, Krajcar M, Hummelgen M, Kompa S, Heusch G. Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide. Circulation 1994; 90:1368-1385.
60. 60 Auchampach JA, Maruyama M, Cavero I, Gross GJ. Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning. Circulation 1992; 86:311-319.
61. 61 Pagel PS, Hettrick DA, Montgomery MW, Kersten JR, Steffen RP, Warltier DC. RSR13, a synthetic modifier of hemoglobin-oxygen affinity, enhances the recovery of stunned myocardium in anesthetized dogs. J Pharmacol Exp Ther 1998; 285:1-8.
62. 62 Elliott GT, Mei DA, Gross GJ. Monophosphoryl lipid A attenuates myocardial stunning in dogs: role of ATP-sensitive potassium channels. J Cardiovasc Pharmacol 1998; 32:49-56.
63. 63 Warltier DC, al-Wathiqui MH, Kampine JP, Schmeling WT. Recovery of contractile function of stunned myocardium in chronically instrumented dogs is enhanced by halothane or isoflurane. Anesthesiology 1988; 69:552-565. This is the first study to show beneficial effects of volatile anesthetics on the recovery of myocardial stunning in intact animals.
64. 64 Freedman BM, Hamm DP, Everson CT, Wechsler AS, Christian CMD. Enflurane enhances postischemic functional recovery in the isolated rat heart. Anesthesiology 1985; 62:29-33.
65. 65 Belo SE, Mazer CD. Effect of halothane and isoflurane on postischemic 'stunned' myocardium in the dog. Anesthesiology 1990; 73:1243-1251.
66. 66 Blanck TJ, Peterson CV, Baroody B, Tegazzin V, Lou J. Halothane, enflurane, and isoflurane stimulate calcium leakage from rabbit sarcoplasmic reticulum. Anesthesiology 1992; 76:813-821.
67. 67 Rusy BF, Komai H. Anesthetic depression of myocardial contractility: a review of possible mechanisms. Anesthesiology 1987; 67:745-766.
68. 2+ mobilization in single rat ventricular myocytes. Anesthesiology 1991; 75:1075-1086.
69. ATP) channels. Anesthesiology 1996; 85:794-807.
70. ATP channel antagonist, attenuates the cardioprotective effects of isoflurane in stunned myocardium. Anesth Analg 1996; 83:27-33.
71. 71 Siker D, Pagel PS, Pelc LR, Kampine JP, Schmeling WT, Warltier DC. Nitrous oxide impairs functional recovery of stunned myocardium in barbiturate-anesthetized, acutely instrumented dogs. Anesth Analg 1992; 75:539-548.